Polygenic risk for AD including APOE was found to associate with plasma p-tau181 independent of diagnostic status and Aβ pathology status, while polygenic risk for AD beyond APOE was associated with plasma p-tau181 only in MCI patients and Aβ-positive individuals. Here, APOE is linked to Alzheimer disease.